Making India hotter, healthier, and productive.
India has a weight problem — and it's getting worse fast.
1 in 3 Indian adults is overweight. 101 million are diabetic. By 2030, 404 million Indians will have a high BMI. The Economic Survey 2026 flagged obesity as a major public health threat. It's not just a health crisis — it's a productivity crisis.
That solution is GLP-1 therapy — the most significant breakthrough in weight management in decades. Clinically proven to deliver 15–20% weight loss. Already transformed millions of lives globally. And as of March 20, 2026, the semaglutide patent expired in India. Generic versions are now available at ₹1,300–2,200/month — down from ₹10,000+.
The drug is here. The demand is exploding. But the system to deliver it safely, affordably, and at scale — that doesn't exist yet.
Chemists are selling without prescriptions. People are self-medicating from social media tips. Regulators are cracking down. There's no trusted platform where an Indian can go online, consult a real specialist, get a legitimate prescription, and have their medication delivered to their door.
That's Zelta.
Zelta is a doctor-led, AI-powered telehealth platform for GLP-1 weight loss treatment in India.
A patient takes a 2-minute health assessment online, books a video consultation with a verified endocrinologist for ₹499, and — if eligible — gets prescribed generic semaglutide. The medication is delivered to their door via cold-chain shipping in 3–5 days. Monthly follow-ups, dosage adjustments, and WhatsApp support are included.
All-inclusive: ₹3,999/month. That's 50–65% cheaper than branded Ozempic, with the convenience of never leaving home and the safety of specialist supervision.
We don't stock drugs. We don't employ doctors full-time. We don't run pharmacies. We're the technology layer that makes the entire experience seamless — connecting patients to specialists and pharmacies through AI-powered operations.
| Area | Owner |
|---|---|
| Product & Strategy | Sowmay |
| Doctor Network & Medical Ops | Ravi & Naksh |
| Pharmacy & Fulfillment | Ravi & Naksh |
| Logistics & Delivery | Dilisha & Misba |
| Ads & Growth | Kuber |
| Content & Social | Aisurya |
| Payments, Infra & Compliance | Nikhil & Ankit |
| Technology & AI Ops | Lauki (AI) |
"A one-person business worth $1 billion would have been unimaginable without A.I., and now it will happen."
— Sam Altman, CEO of OpenAI
It already happened in the US. Now it's India's turn.